Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

Marks also received high praise from leaders in the cell and gene therapy field and spoke frequently about the need for ... streamlining new drug submissions to expediting the development of ...

has the promise to lead to new paradigms and cost savings in drug development, all of which would strengthen the industry and its ability to develop innovative and much-needed therapies for ...

Developers and researchers from diverse backgrounds can quickly evaluate and validate new ... need to meet regulatory standards, as well as the long timelines that are inherent in drug development.

Drug researchers also find that AI leads to more robust and decisive drug development decisions, which gets better products to the patients who need them ... AI to develop new medicines.

Trump’s administration this week abruptly terminated funding for a slew of studies designed to learn how to better treat the ...

By contrast, GLP-1 receptor agonists, the class of weight-loss drugs that includes Wegovy, Mounjaro and Zepbound, really do seem poised to ... 25% weight loss in many people with the new medicines ...

In this article, you can learn about the rights to brand-name drugs, such as Wegovy, in the United States. You can also learn how these rights concern the development ... the new drug is safe ...

Bioconjugation creates new molecules with increased ... addressing the critical need for specialised materials in drug delivery and biomolecule analysis. Their expertise spans all stages of ...